On track to complete enrollment for the Phase 3 PROACT 1 accelerated approval analysis of rilparencel in mid-2026; anticipate pivotal topline ...

Researchers developed a compound that protects the liver after small bowel resection in mice. The drug improved nutrient absorption, reduced fibrosis, and avoided systemic side effects, offering hope ...

Q4 2025 Earnings Call March 16, 2026 8:00 AM EDTCompany ParticipantsKristal Li - Investor Relations ManagerYan Li - Chairman, ...

ACI-7104 Phase 2 data and mid-2026 readout, plus FY25 cash burn and dilution risk—see key catalysts and what to do now.

Week Study to Evaluate One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., March 18, 2026 ...

Weibo Corporation ("Weibo" or the "Company") (Nasdaq: WB and HKEX: 9898), a leading social media in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended ...

Positive interim Phase 1/2 INSPIRE DUCHENNE data reported at the 2026 MDA Annual Meeting continued to suggest differentiated clinical, safety and tolerability profiles; SGT-003 has been generally well ...

Incumbents Ted Kowalski, Gee Pope, Elizabeth Potter-Nelson and Alex Sommers will face challengers Miguel Campos, Jeff Ebel ...

An American winery closed almost every day of 2025, as Trump tariffs resulted in an almost 80% drop of Canadian consumption ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.

Increase in Q4 2025 Revenue to $6.2 Million. Introduces Merlin Constellation, a Fully Funded AI-First Global Daily Remapping System at 1-Meter Resolution, Targeted for October ...